Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis.
Clinical trial NCT02174731 · COMPLETED
Trial details
- NCT number
- NCT02174731
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2018-09-26
- Enrollment
- 2133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.